NCT Number: NCT00000176
Alzheimer's Disease Prevention Trial
This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.
Looking for future studies?
Notify MeKey information
Conditions
Age range
65 year and older
Sex eligibility
Female
Study type
Interventional
Phase
Phase 3
Primary location
University of Alabama, Birmingham, Alabama, United States
About this study
PREventing Postmenopausal memory loss and Alzheimer's with Replacement Estrogens (PREPARE) is a double-blind-placebo controlled trial to determine whether estrogen (or estrogen and progesterone) can delay the onset of memory loss or Alzheimer's Disease in elderly women with a family history of the disease.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Healthy women 65 or older with a family history of memory problems not currently on estrogen.
Exclusion criteria
- Significant neurological impairment
- Current estrogen use
- History of breast cancer
Treatment and study plan
Estrogen and Progesterone
DrugSponsors and collaborators
Lead sponsor
National Institute on Aging (NIA)
Nih
Registry information
Official study title
Alzheimer's Disease Prevention Trial. A Multi-center, Randomized, Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimer's Disease and Loss of Memory in Women.
Important dates
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Nov 1, 1999
- Registry last updated
- Nov 5, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Virtual Reality Cognitive Stimulation for Alzheimer's
NCT07645638
Alzheimer Disease, Brain Diseases
Burgos, Spain
View Trial DetailsIdentification of Patients With a High Probability of Meeting Eligibility Criteria for an Alzheimer's Disease Clinical Trial (APHELEIA)
NCT05364307
Alzheimer Disease, Brain Diseases
San Diego, California, United States
View Trial DetailsEvaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI)
NCT02843529
Alzheimer Disease, Asymptomatic Diseases
View Trial DetailsCare Ecosystem: Navigating Patients and Families Through Stages of Care
NCT02213458
Alzheimer Disease, Arterial Occlusive Diseases
San Francisco, California, United States
View Trial Details